BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15301723)

  • 1. [Immunophenotype analysis in 121 patients with lymphoproliferative diseases by flow cytometry].
    Sun XM; Chen JH; Xu JY; Zhang YF; Xie PH; Fan XN; Xie W
    Ai Zheng; 2004 Aug; 23(8):955-7. PubMed ID: 15301723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
    Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous cytomorphologic and multiparametric flow cytometric analysis on lymph node samples is faster than and as valid as histopathologic study to diagnose most non-Hodgkin lymphomas.
    Colorado M; Cuadrado MA; Insunza A; Mazorra F; Acinas O; Iriondo A
    Am J Clin Pathol; 2010 Jan; 133(1):83-91. PubMed ID: 20023262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of lymphoproliferative disorders: experience of a single institution in the long-term follow-up of discordant cases.
    Sadek I; Greer W; Foyle A
    Clin Invest Med; 2000 Dec; 23(6):366-75. PubMed ID: 11152404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies.
    Martínez A; Aymerich M; Castillo M; Colomer D; Bellosillo B; Campo E; Villamor N
    Cytometry B Clin Cytom; 2003 Nov; 56(1):8-15. PubMed ID: 14582132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma discrimination by computerized triple matrix analysis of list mode data from three-color flow cytometric immunophenotypes of bone marrow aspirates.
    Bartsch R; Arland M; Lange S; Kahl C; Valet G; Höffkes HG
    Cytometry; 2000 Sep; 41(1):9-18. PubMed ID: 10942891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of lymphomas and lymphoproliferative disorders.
    Stetler-Stevenson M; Braylan RC
    Semin Hematol; 2001 Apr; 38(2):111-23. PubMed ID: 11309693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fine needle aspirate of lymph node as the analytical sample for immunophenotyping].
    Svencbir V; Anić V; Siftar Z; Paro MM; Kolonić SO; Bolanca IK; Kardum-Skelin I
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():81-8. PubMed ID: 23126034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
    Klujber V; Koós R; Schuler D; Bocsi J
    Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient characterization of the TCR repertoire in lymph nodes by flow cytometry.
    Salameire D; Le Bris Y; Fabre B; Fauconnier J; Solly F; Pernollet M; Bonnefoix T; Leroux D; Plumas J; Jacob MC
    Cytometry A; 2009 Sep; 75(9):743-51. PubMed ID: 19582873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
    Zhang QY; Foucar K
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):873-902. PubMed ID: 19577173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking the follicular lymphoma cells in flow cytometry: characterisation of a new useful antibody combination.
    Detry G; Drénou B; Ferrant A; Theate I; Michaux L; Scheiff JM; Latinne D; Leveugle P; Mazzon AM; Deneys V
    Eur J Haematol; 2004 Nov; 73(5):325-31. PubMed ID: 15458511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of flow cytometry in the diagnosis of lymphoma: a critical analysis.
    Morse EE; Yamase HT; Greenberg BR; Sporn J; Harshaw SA; Kiraly TR; Ziemba RA; Fallon MA
    Ann Clin Lab Sci; 1994; 24(1):6-11. PubMed ID: 8147568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin's lymphoma in AIDS patients.
    Subirá D; Górgolas M; Castañón S; Serrano C; Román A; Rivas F; Tomás JF
    HIV Med; 2005 Jan; 6(1):21-6. PubMed ID: 15670248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine needle aspiration for flow cytometry immunophenotyping of non Hodgkin lymphoma.
    Sapia S; Sánchez Avalos JC; Monreal M; Galeano A; González Villaveiran R; Cornicelli J; Gamboni M
    Medicina (B Aires); 1995; 55(6):675-80. PubMed ID: 8731578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.